Abstract
Background The abscopal effect is a phenomenon where a tumor that is not the intended site of treatment also shrinks in response to therapy; and is one of the most coveted and rare effects of cancer therapies. Previous attempts to summarize literature on the abscopal effect have focused on specific disease sites or been done on a limited basis. We performed a comprehensive review of every publication and case report regarding the abscopal effect induced by radiotherapy from the 1950s to February 2023 to identify potential trends and patterns in its induction based on specific disease/ treatment site, radiation dose, and other factors.
Methods
Literature that described the abscopal effect was identified through search of online databases: Pubmed, Medline, and Google Scholar for all published articles from 1953 leading to February of 2023 that included the terms “Abscopal Effect” and “Radiation” or “Radiotherapy.” Demographics (patient and tumor characteristics), radiation and abscopal effect analysis, outcome and treatment analysis, and risk of bias were reported and summarized.
Results
A final total of 92 papers corresponding to 99 separate lesions or cases were included in the meta-analysis. The most common site of induction of the abscopal effect and of the target of the abscopal effect was the lung. One manuscript reported a nonstandard treatment protocol, the remainder of cases received radiation within reasonable treatment guidelines. The majority of manuscripts included most important information (cancer site, number of prior treatments, histopathology, outcome information, and dose).
Conclusion
Additional research is urgently needed to understand how and why some treatment regimes are able to induce the abscopal effect. For the time being, this remains a rare phenomenon.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
dprovenzano23{at}gwu.edu; loew{at}gwu.edu; shgoyal{at}mfa.gwu.edu; yrao{at}mfa.gwu.edu
Data Availability
All data produced are available online at citations listed within the article.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.